Defunctioning polymorphism in the immunoglobulin G inhibitory receptor (FcγRIIB-T/T232) does not impact on kidney transplant or recipient survival

Background - There is an increasing appreciation of the deleterious effects of antibody and B cells on acute and chronic transplant outcomes. Many effector functions of antibody are mediated by a family of receptors (FcγRs) that are expressed on most immune cells, including neutrophils, nat...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Clatworthy, Menna R. (VerfasserIn) , Matthews, Rebeccah J. (VerfasserIn) , Doehler, Bernd (VerfasserIn) , Willcocks, Lisa C. (VerfasserIn) , Opelz, Gerhard (VerfasserIn) , Smith, Kenneth G. C. (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 2014
In: Transplantation
Year: 2014, Jahrgang: 98, Heft: 3, Pages: 285-291
ISSN:1534-6080
DOI:10.1097/TP.0000000000000287
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1097/TP.0000000000000287
Verlag, lizenzpflichtig, Volltext: https://journals.lww.com/transplantjournal/Fulltext/2014/08150/Defunctioning_Polymorphism_in_the_Immunoglobulin_G.11.aspx
Volltext
Verfasserangaben:Menna R. Clatworthy, Rebeccah J. Matthews, Bernd Doehler, Lisa C. Willcocks, Gerhard Opelz, and Kenneth G.C. Smith
Beschreibung
Zusammenfassung:Background - There is an increasing appreciation of the deleterious effects of antibody and B cells on acute and chronic transplant outcomes. Many effector functions of antibody are mediated by a family of receptors (FcγRs) that are expressed on most immune cells, including neutrophils, natural killer cells, and B cells. Most FcγRs are activating and controlled by a single inhibitory receptor, FcγRIIB (CD32B), which also regulates some aspects of B-cell activation and antibody production. FcγRIIB-deficient mice develop severe chronic arteriopathy in a murine cardiac allograft model. A single nucleotide polymorphism in human FcγRIIB (rs1050501) results in profound receptor dysfunction and is associated with systemic lupus erythematosus. The frequency of this FcγRIIB-I/T232 polymorphism also shows significant racial variation. - Methods - In the present study, we sought to determine whether the FcγRIIB-I/T232 single nucleotide polymorphism rs1050501 affected susceptibility to renal allograft rejection or loss and transplant recipient survival. FcγRIIB-I/T232 genotype was determined in 2,851 Caucasian and 570 Afro-Caribbean renal transplant recipients, and in 236 transplant recipients with a primary diagnosis of systemic lupus erythematosus, all of whom were enrolled into the Collaborative Transplant Study. - Results - We found no significant difference in pretransplant panel reactive antibodies, acute rejection at 1-year nor in 10-year transplant or patient survival in individuals with differing FcγRIIB-I/T232 genotype. - Conclusion - This negative result is surprising, given the importance of this receptor in modulating antibody effector function.
Beschreibung:Gesehen am 11.09.2020
Beschreibung:Online Resource
ISSN:1534-6080
DOI:10.1097/TP.0000000000000287